His primary scientific interests are in Pathology, Alzheimer's disease, Internal medicine, Dementia and Frontotemporal dementia. His Pathology research focuses on C9orf72 and Amyotrophic lateral sclerosis. His studies deal with areas such as Biomarker, Positron emission tomography, Nuclear medicine and Amyloid as well as Alzheimer's disease.
His studies in Positron emission tomography integrate themes in fields like Concordance, Neuroimaging and Medical imaging. His Internal medicine research incorporates themes from Differential diagnosis and Oncology. His Frontotemporal dementia study incorporates themes from Genetics and Apolipoprotein E.
Neuroscience, Pathology, Disease, Internal medicine and Frontotemporal dementia are his primary areas of study. His Pathology study is mostly concerned with Amyloid and Alzheimer's disease. The study incorporates disciplines such as Neurology, Cerebrospinal fluid and Bioinformatics in addition to Disease.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Oncology. His Frontotemporal dementia research is multidisciplinary, relying on both Genetics and Atrophy. His biological study spans a wide range of topics, including Apolipoprotein E and Cognition.
His scientific interests lie mostly in Frontotemporal dementia, Disease, Internal medicine, Pathology and C9orf72. His Frontotemporal dementia study introduces a deeper knowledge of Dementia. His Dementia research includes themes of Genotype and Biomarker discovery.
His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Oncology. His Tauopathy, Neuropathology and Frontotemporal lobar degeneration study in the realm of Pathology interacts with subjects such as Amyloid pathology. The Frontotemporal lobar degeneration study combines topics in areas such as Neurofibrillary tangle and Amyotrophic lateral sclerosis.
His primary areas of study are Frontotemporal dementia, Dementia, Internal medicine, Disease and C9orf72. His work carried out in the field of Frontotemporal dementia brings together such families of science as Pathological, Cohort study, Apathy, Pediatrics and Atrophy. His research integrates issues of Apolipoprotein E, Biomarker discovery and Amyloid in his study of Dementia.
His Internal medicine research incorporates elements of Gastroenterology, Oncology and Cardiology. His C9orf72 study combines topics from a wide range of disciplines, such as Biomarker and Frontotemporal lobar degeneration. In his work, Pathology is strongly intertwined with Hippocampal formation, which is a subfield of Frontotemporal lobar degeneration.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Classification of primary progressive aphasia and its variants
M L Gorno-Tempini;M L Gorno-Tempini;A E Hillis;S Weintraub;A Kertesz.
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21
Marc Cruts;Ilse Gijselinck;Julie van der Zee;Sebastiaan Engelborghs.
Functional anatomy of a common semantic system for words and pictures
R. Vandenberghe;C. Price;R. Wise;O. Josephs.
A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.
Ilse Gijselinck;Tim Van Langenhove;Julie van der Zee;Kristel Sleegers.
Lancet Neurology (2012)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez.
Nature Genetics (2017)
18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment : a phase 2 trial.
Rik Vandenberghe;Rik Vandenberghe;Koen Van Laere;Adrian Ivanoiu;Eric Salmon.
Annals of Neurology (2010)
The neural systems sustaining face and proper-name processing.
M L Gorno-Tempini;C J Price;O Josephs;Rik Vandenberghe.
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
Rik Ossenkoppele;Willemijn J Jansen;Gil D Rabinovici;Dirk L Knol.
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
Michael F. Egan;James Kost;Pierre N. Tariot;Paul S. Aisen.
The New England Journal of Medicine (2018)
The Response of Left Temporal Cortex to Sentences
R. Vandenberghe;A. C. Nobre;C. J. Price.
Journal of Cognitive Neuroscience (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: